Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Vaccination and timely treatment reduce the risk of long COVID.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

SIM01 significantly reduced post-COVID symptoms and is safe.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

No significant link between male pattern baldness and COVID-19 severity was found.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Protein analysis shows aging changes in scalp cell types from women.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Skin aging and cancer development are influenced by the competition between stem cells.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Human-induced stem cell-created skin models can help understand skin diseases by studying the skin's layers.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.